MedTrace Logo

Advanced GC Multi-omic Characterization in EU and CELAC Populations

NCT04015466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2024-05-09

No results posted yet for this study

Summary

Observational study (cohort type) of advanced GC patients that will be recruited prospectively to study biological factors associated with the disease and relevant clinical outcomes.

Conditions

Sponsors & Collaborators

  • Instituto Nacional de Cancerologia de Mexico

    collaborator OTHER

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • Pontificia Universidad Catolica de Chile

    collaborator OTHER

  • Vall d'Hebron Institute of Oncology

    collaborator OTHER

  • INSTITUTO ALEXANDER FLEMING

    collaborator UNKNOWN

  • Hospital Central del IPS

    collaborator OTHER

  • IPATIMUP - Instituto De Patologia E Imunologia Molecular Da Universidade Do Porto

    collaborator OTHER

  • Fundación para la Investigación del Hospital Clínico de Valencia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-12
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Argentina
  • Chile
  • Mexico
  • Netherlands
  • Paraguay
  • Portugal
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04015466 on ClinicalTrials.gov